DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) was the target of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 38,400 shares, a decrease of 46.4% from the October 31st total of 71,600 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.
DiaSorin Stock Performance
Shares of OTCMKTS DSRLF remained flat at $107.88 during mid-day trading on Friday. The business’s 50 day moving average is $103.07 and its 200 day moving average is $103.07. DiaSorin has a 52-week low of $107.88 and a 52-week high of $107.88.
Wall Street Analysts Forecast Growth
Separately, UBS Group downgraded shares of DiaSorin from a “strong-buy” rating to a “hold” rating in a research report on Tuesday.
About DiaSorin
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Recommended Stories
- Five stocks we like better than DiaSorin
- How to Invest in the FAANG Stocks
- ServiceNow: Will the High-Flyer Finally Split in 2024?
- What is a Special Dividend?
- MarketBeat Week in Review – 11/25 – 11/29
- What is a Dividend King?
- These 3 Stocks Are Heavy Hitters in Alternative Asset Management
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.